Labeling & Marketing Compliance Spec

Version 2026.05.22. This is the controlling spec for what must appear on every vial, every outer package, and in all marketing. The goal: keep the product unambiguously Research Use Only and never make it look like a drug, supplement, or cosmetic. Have Maryland-licensed regulatory counsel sign off on this spec before the first lot ships.

1. Vial label (the 2"×1" generated in admin → Labels)

Must contain, legibly:

• Product name + SKU (e.g. "BPC-157 · BPC")
• Net quantity (e.g. "5 mg lyophilized")
• Lot number (matches the public COA library)
• Manufacture date and expiry date
• Storage condition ("Store −20°C, protect from light")
• Purity statement tied to the COA ("≥99% HPLC, see COA")
• "FOR RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE" (must be present and conspicuous)
• "Not a drug, supplement, food, or cosmetic"
• Company name + US location ("X Factor Research LLC (DBA X Factor Peptides) · Maryland, USA")
• A Code-128 barcode encoding the lot for scan-to-pick

Must NOT contain:

• Any dose, dosing instruction, route of administration, or frequency
• Any therapeutic, structure/function, disease, or wellness claim
• Any "supplement facts" or "drug facts" style panel
• Any human-use imagery or implication

2. Outer package

• Discreet plain mailer with the company return address
• Outer label states "Research chemicals — not for human use"
• No product names visible externally (privacy + avoids implying retail consumer product)
• Cold-pack inserted for blends or on request, with a "keep refrigerated on arrival — research material" insert

3. Packing slip (generated in admin → Pick & Pack)

• Order number, lot per line item, ship-to
• RUO restatement
• QR code to the order-tracking / RMA portal
• No pricing-per-use, no dosing, no human-use language

4. Insert card (every shipment)

• RUO statement, storage guidance, COA lookup URL (/coa/)
• "Questions about the lot? [email protected]"
• Reconstitution-math pointer to /reconstitution.html with the explicit note: "calculates concentration only; it does not tell you how much to administer because we do not provide that"

5. Marketing & site copy rules (FTC + FDA posture)

• Never claim or imply human benefit, treatment, cure, prevention, or wellness outcome.
• Never use before/after imagery, testimonials about personal results, or influencer "I used this" content.
• Mechanism content must be framed as published preclinical / in-vitro literature, cited, in the third person ("studies report…"), never as instructions.
• Affiliates must carry the FTC 16 CFR Part 255 disclosure and may not market for human use (enforced in the Acceptable Use Policy).
• Email subject lines and ad copy follow the same rules; no "lose weight," "heal," "anti-aging," etc.
• The persistent ribbon, checkout attestation, and footer disclosure repeat the RUO posture on every page.

6. Prohibited terms list (lint these out everywhere — chatbot, support, copy, email)

dose, dosage, administer, inject, injection, treat, treatment, cure, prevent, diagnose, therapy, therapeutic, prescription, supplement benefit, weight loss, anti-aging, healing, recovery protocol (when addressed to a person), "for you", "your body".

7. Records

Keep a label proof + the controlling COA for every lot in the 7-year record. The admin audit log records each label generation event.

8. Review cadence

Counsel reviews this spec quarterly or whenever a new SKU, claim, or marketing channel is added.